Prestige Brands Holdings, Inc. to Release Fiscal 2013 Fourth Quarter & Year-End Earnings on May 16th Company’s First Investor Day Planned for May 22nd Business Wire TARRYTOWN, N.Y. -- April 18, 2013 Prestige Brands Holdings, Inc. (NYSE: PBH) today announced that it will issue its fiscal 2013 fourth quarter and year-end earnings release on Thursday, May 16, 2013 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. EST. To access the call, listeners calling from within North America may dial (866) 318-8613 about 15 minutes prior to the start of the call. Those wishing to access the call from outside North America should dial (617) 399-5132. The conference passcode is “prestige”. The Company will provide a live internet web cast as well as an archived replay, which can be accessed from the Investor Relations page of http://prestigebrands.com. Telephonic replays will be available for two weeks following completion of the live call and can be accessed at (888) 286-8010 within North America, and at (617) 801-6888 from outside North America. The passcode is 69473606. First Investor Day The Company will host its first Investor Day on Wednesday, May 22, beginning at 10:30 a.m. EST. CEO Matthew Mannelly and other members of senior management will present an overview of the Company’s operational and financial strategy. The Company will provide a live internet webcast which can be accessed from the Investor Relations page of http://prestigebrands.com. Choose the “Click here for webcast” hyperlink and register for access. A replay of the full event will be available via the same URL three hours after the event. Visit the “News and Events” section of the Company’s website for details of the event. Prestige Brands markets and distributes brand name over-the-counter healthcare and household products throughout the United States and Canada and in certain international markets. Key brands include Chloraseptic^® sore throat treatments, Compound W^® wart treatments, Clear Eyes^® eye care products, Little Remedies^® and PediaCare^® pediatric over-the-counter healthcare products, The Doctor’s^® NightGuard® dental protector, Efferdent^® denture care products, Luden’s^® throat drops, Dramamine^® motion sickness treatment, BC^® and Goody’s^® headache remedies, Beano^® gas prevention, Debrox^® earwax remover, and in Canada, Gaviscon^® antacid. Contact: Prestige Brands Holdings, Inc. Dean Siegal, 914-524-6819
Prestige Brands Holdings, Inc. to Release Fiscal 2013 Fourth Quarter & Year-End Earnings on May 16th
Press spacebar to pause and continue. Press esc to stop.